Article
Partnering with General Practitioners to Optimize Survivorship for Patients with Lymphoma: A phase II Randomized Controlled Trial (The GOSPEL 1 Trial)
2020-08-25
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Survival rates for lymphoma are highest amongst hematological malignancies. In 2019, it was estimated that over 6,400 Australians were diagnosed with lymphoma, a group of hematological malignancies with a high 5-year survival rate of ~76%. There is an increased focus on the promotion of wellness in survivorship and active approaches to reducing morbidity related...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- afbd6579-0666-5486-8234-d84820ee49f6
- DOI
- 10.21203/rs.3.rs-32868/v1
